The Medicines Company
Part of Novartis
CompanyUnited StatesFounded 1996
The Medicines Company develops one asset, approved (inclisiran in hypercholesterolemia). Mostly oligonucleotide acting on PCSK9; based in the United States, founded in 1996.
- 1
- Asset
- Furthest stage
- Approved
- 23
- Trials
- 75
- Signals
Pipeline
1Silences hepatic PCSK9 expression, increasing LDL receptor recycling and lowering circulating LDL cholesterol.
Approved, Oligonucleotide, PCSK9, hypercholesterolemia, heterozygous familial hypercholesterolemia
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms2
- Trials25
- Signals20
- Similar companies6